Bupivacaine PatchPump - SteadyMed TherapeuticsAlternative Names: SMT-301
Latest Information Update: 18 Aug 2015
At a glance
- Originator SteadyMed Therapeutics
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Small molecules
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Pain